As announced in the ad-hoc release of December 13, 2022, MEDIQON Group AG has successfully completed a capital increase.

The company raised EUR 15.5 million in equity by issuing 1,067,267 shares. The shares were subscribed by new shareholders as well as our long-term anchor investors.

The proceeds from the capital increase will be invested to further accelerate the Group’s growth.

Jan-Hendrik Mohr, CEO of MEDIQON Group AG commented:
“The platform companies of MEDIQON Group AG are growing stronger than expected. We are very pleased with the positive development of the Group in a challenging environment. We would like to thank our teams for the excellent job in developing the Group’s companies in 2022.“

Today’s capital increase is a great vote of confidence from our shareholders and we welcome all new investors to the next chapter of our development!”